APA

De Cola A., Volpe S., Budani M. C., Ferracin M., Lattanzio R., Turdo A., D'Agostino D., Capone E., Stassi G., Todaro M., Di Ilio C., Sala G., Piantelli M., Negrini M., Veronese A. & De Laurenzi V. (20160510). miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. : Cell death & disease.

Chicago

De Cola A, Volpe S, Budani M C, Ferracin M, Lattanzio R, Turdo A, D'Agostino D, Capone E, Stassi G, Todaro M, Di Ilio C, Sala G, Piantelli M, Negrini M, Veronese A and De Laurenzi V. 20160510. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. : Cell death & disease.

Harvard

De Cola A., Volpe S., Budani M. C., Ferracin M., Lattanzio R., Turdo A., D'Agostino D., Capone E., Stassi G., Todaro M., Di Ilio C., Sala G., Piantelli M., Negrini M., Veronese A. and De Laurenzi V. (20160510). miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. : Cell death & disease.

MLA

De Cola A, Volpe S, Budani M C, Ferracin M, Lattanzio R, Turdo A, D'Agostino D, Capone E, Stassi G, Todaro M, Di Ilio C, Sala G, Piantelli M, Negrini M, Veronese A and De Laurenzi V. miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. : Cell death & disease. 20160510.